Summary of Key Points Core Viewpoint - The announcement provides an update on the conversion of the company's convertible bonds into common shares, detailing the cumulative conversion amounts and the remaining unconverted bonds. Group 1: Conversion Status - As of June 30, 2025, a total of 1.719 million yuan of "Saili Convertible Bonds" has been converted into 114,799 shares, representing 0.0560% of the company's total share capital before conversion [2][9]. - The amount of unconverted "Saili Convertible Bonds" as of June 30, 2025, is 417.811 million yuan, accounting for 76.9010% of the total issuance [2][9]. - During the period from April 1, 2025, to June 30, 2025, the cumulative conversion amount was 17,000 yuan, resulting in 1,414 shares, which is 0.0007% of the total share capital before conversion [2][9]. Group 2: Convertible Bond Issuance Overview - The company issued 5.4331 million convertible bonds on August 21, 2020, with a total value of 54.331 million yuan and a maturity of six years [3][4]. - The initial coupon rates for the bonds are set at 0.50% for the first year, increasing to 3.00% by the sixth year [3]. Group 3: Conversion Price Adjustments - The initial conversion price was set at 16.98 yuan per share, which was subsequently adjusted downwards to 13.71 yuan on September 9, 2024, and further to 12.71 yuan on October 28, 2024 [5][7]. - The conversion price was later adjusted to 12.50 yuan due to share buybacks and cancellations, and then further reduced to 12.00 yuan on February 10, 2025 [8][9]. Group 4: Share Capital Changes - The total share capital increased by 1,414 shares due to the conversion of convertible bonds during the specified period [10]. - The company also experienced a reduction in share capital due to the cancellation of shares from buybacks, totaling 10,371,040 shares [11].
塞力斯医疗科技集团股份有限公司可转债转股结果暨股份变动公告